{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":24,"n_cols":5,"rows_kept":24,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910457486903321"]
[null,null,"Autore",null,"Comandone Alessandro"]
[null,null,"Titolo",null,"Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone"]
[null,null,"Pubbl/distr/stampa",null,"Torino, : SEEd, 2011"]
[null,null,"ISBN",null,"88-97419-08-9"]
[null,null,"Descrizione fisica",null,"1 online resource (144 p.)"]
[null,null,"Disciplina",null,"617.4/4"]
[{"$nulls":4},"617.44"]
[null,null,"Soggetti",null,"Tumors"]
[{"$nulls":4},"Chemotherapy"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin"]
[{"$nulls":4},"Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil"]
[{"$nulls":4},"GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine "]
[{"$nulls":4},"tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers"]
[{"$nulls":4},"Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin"]
[{"$nulls":4},"Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB"]
[{"$nulls":4},"Testicular tumors: VeIP (rescue regimen)"]
[null,null,null,"Sommario/riassunto","Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we report a short description of the hematologic toxicities related to the treatment."]